New Three-Drug Therapy Offers Hope for Advanced Breast Cancer

A new drug combination could double survival time for advanced breast cancer patients. Researchers have developed a therapy targeting a common form of aggressive breast cancer, offering hope for prolonged life. A trial involving 325 patients across 28 countries tested a three-drug combo, including two targeted drugs—palbociclib and inavolisib. The drugs target the PI3K protein, a driver of cancer growth, alongside hormone therapy.